Tag: Paul Perreault
Paul McKenzie to take reins as CSL’s new CEO, managing director
Global biotechnology giant CSL Limited has named Paul McKenzie as its chief executive officer and managing director, effective 6 March 2023.Â
CSL boosts AU’s plasma manufacturing capability with new Fractionation Facility
Global biotech company CSL has opened a new $900 million Plasma Fractionation Facility in Victoria, bolstering the future of plasma manufacturing in Australia.Â
CSL completes acquisition of novel gene therapy for haemophilia B
CSL Limited has wrapped up the acquisition of uniQure’s etranacogene dezaparvovec, a novel gene therapy for the treatment of haemophilia B.
Under the agreement, CSL...
Featured Article
What spending reveals about downstream consumer demand for manufactured goods
For manufacturers supplying consumer-facing markets, understanding demand conditions has become increasingly important in an environment shaped by cautious spending, rising costs and intense competition.
